Advertisement
Screener

BIOCLINICA INC Net Income

BIOCLINICA INC Net Income

BIOCLINICA INC reported Net Income of $3.73 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-22.

Discontinued › Income Statement

us-gaap:NetIncomeLoss · last filed 2013-02-22

  • BIOCLINICA INC net income (loss) attributable to parent for the quarter ending 2012-12-31 was $1.16M, a 0.60% decline year-over-year.
  • BIOCLINICA INC net income (loss) attributable to parent for the quarter ending 2012-09-30 was $542.00K, a 51.40% increase year-over-year.
  • BIOCLINICA INC net income (loss) attributable to parent for the quarter ending 2012-06-30 was $1.03M, a 11.80% increase year-over-year.
  • BIOCLINICA INC net income (loss) attributable to parent for the quarter ending 2012-03-31 was $994.00K, a 183.19% increase year-over-year.
  • BIOCLINICA INC net income (loss) attributable to parent for fiscal 2012 was $3.73M, a 33.20% increase from fiscal 2011.
  • BIOCLINICA INC net income (loss) attributable to parent for fiscal 2011 was $2.80M, a 1.63% increase from fiscal 2010.
  • BIOCLINICA INC net income (loss) attributable to parent for fiscal 2010 was $2.75M, a 6.96% decline from fiscal 2009.
  • BIOCLINICA INC net income (loss) attributable to parent for fiscal 2009 was $2.96M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 month
2012-12-31$1.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$1.70M
derived: sum of 2 quarters · filed 2013-02-22
$2.73M
derived: sum of 3 quarters · filed 2013-02-22
$3.73M
10-K · filed 2013-02-22
2012-09-30$542.00K
10-Q · filed 2012-11-09
$1.57M
derived: sum of 2 quarters · filed 2012-11-09
$2.57M
10-Q · filed 2012-11-09
$3.73M
derived: sum of 4 quarters · filed 2013-02-22
2012-06-30$1.03M
10-Q · filed 2012-08-09
$2.03M
10-Q · filed 2012-08-09
$3.19M
derived: sum of 3 quarters · filed 2013-02-22
$3.55M
derived: sum of 4 quarters · filed 2013-02-22
2012-03-31$994.00K
10-Q · filed 2012-05-10
$2.16M
derived: sum of 2 quarters · filed 2013-02-22
$2.52M
derived: sum of 3 quarters · filed 2013-02-22
$3.44M
derived: sum of 4 quarters · filed 2013-02-22
2011-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$1.52M
derived: sum of 2 quarters · filed 2013-02-22
$2.45M
derived: sum of 3 quarters · filed 2013-02-22
$2.80M
10-K · filed 2013-02-22
2011-09-30$358.00K
10-Q · filed 2012-11-09
$1.28M
derived: sum of 2 quarters · filed 2012-11-09
$1.63M
10-Q · filed 2012-11-09
$2.46M
derived: sum of 4 quarters · filed 2013-02-22
2011-06-30$924.00K
10-Q · filed 2012-08-09
$1.27M
10-Q · filed 2012-08-09
$2.11M
derived: sum of 3 quarters · filed 2013-02-22
$2.91M
derived: sum of 4 quarters · filed 2013-02-22
2011-03-31$351.00K
10-Q · filed 2012-05-10
$1.18M
derived: sum of 2 quarters · filed 2013-02-22
$1.99M
derived: sum of 3 quarters · filed 2013-02-22
$2.39M
derived: sum of 4 quarters · filed 2013-02-22
2010-12-31$831.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$1.64M
derived: sum of 2 quarters · filed 2013-02-22
$2.04M
derived: sum of 3 quarters · filed 2013-02-22
$2.75M
10-K · filed 2013-02-22
2010-09-30$808.00K
10-Q · filed 2011-11-14
$1.21M
derived: sum of 2 quarters · filed 2011-11-14
$1.92M
10-Q · filed 2011-11-14
2010-06-30$403.00K
10-Q · filed 2011-08-08
$1.11M
10-Q · filed 2011-08-08
2009-12-31$2.96M
10-K · filed 2012-02-27